Skip to main content
. 2019 Jul 10;10:1580. doi: 10.3389/fimmu.2019.01580

Table 1.

OAC cohort demographics.

Biopsies (n = 47) Blood (n = 79)
Gender (M:F) 42:5 70:9
Median age (range), years 64.2 (28–89) 65.1 (28–92)
HISTORY OF BARRETT'S OESOPHAGUS
Yes 14 29
No 17 20
Unknown/Not reported 16 30
TUMOR LOCATION
Type I 21 43
Type II 9 11
Type III 11 16
Not reported 6 9
TUMOR STAGE (CLINICAL)
Tx 0 2
T0 0 1
T1 2 8
T2 4 12
T3 34 45
T4 1 1
Not reported 6 10
NODAL STAGE (CLINICAL)
NX 1 2
N0 16 33
N1 15 19
N2 4 6
N3 5 8
Not reported 6 11
METASTATIC STAGE (CLINICAL)
Mx 5 30
M0 12 10
M1 4 7
Not reported 26 31
PATHOLOGICAL DIFFERENTIATION GRADE
Well 2 3
Moderate 15 37
Poor 30 36
Not reported 0 3
POST-BIOPSY TREATMENT
Neo-adjuvant CROSS 13 23
Neoadjuvant MAGIC 12 27
Other treatment 15 11
Surgery only 3 4
Palliative care 3 6
Unknown 1 8
MANDARD TUMOR REGRESSION GRADE
TRG 1 2 1
TRG 2 2 10
TRG 3 5 10
TRG 4 8 15
TRG 5 7 8